From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...
News Medical on MSN3d
Inhaled antibody therapy shows promise for COVID-19 treatmentThe inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.
New York, United States, Jan. 22, 2025 (GLOBE NEWSWIRE) -- ADCs, or antibody-drug conjugates, are chemotherapeutic agents explicitly designed to treat cancer cells. Antibody-drug conjugates ...
ABBV-154, an antibody-drug conjugate comprising adalimumab conjugated to a proprietary glucocorticoid receptor modulator, shows potential for extending flare-free periods in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback